Blood, 0006-4971

Journal

View graph of relations

Related Publications
  1. No decrease in fracture risk despite 15 years of treatment evolution in multiple myeloma patients: A Danish nationwide case-control study

    Oortgiesen, B., Driessen, A., Hoogendoorn, M., Kibbelaar, R., Veeger, N., Van Der Bergh, J., Vestergaard, P., De Vries, F. & Van Roon, E., 13-Nov-2019, In : Blood. 134, Suppl.1

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Role of disease modifying treatment in the risk of alloimmunization in transfused patients with myelodysplastic syndromes: A population-based study

    Rozema, H., Kibbelaar, R., Veeger, N., Hoogendoorn, M. & Van Roon, E., 13-Nov-2019, In : Blood. 134, Suppl. 1

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Peripheral neuropathy and hypovitaminosis d are associated in multiple myeloma patients

    Oortgiesen, B., Kroes, H., Scholtens, P., Hoogland, J., Dannenberg-De Keijzer, P., Siemes, C., Jansman, F., Kibbelaar, R., Veeger, N., Hoogendoorn, M. & Van Roon, E., 1-Nov-2019, In : Blood. 134, Suppl. 1

    Research output: Contribution to journalArticleAcademicpeer-review

  4. The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

    Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia-Manero, G., Buckstein, R., Santini, V., Diez-Campelo, M., Finelli, C., Cazzola, M., Ilhan, O., Sekeres, M. A., Falantes, J. F., Arrizabalaga, B., Salvi, F., Giai, V., Vyas, P., Bowen, D., Selleslag, D., DeZern, A. E., Jurcic, J. G., Germing, U., Goetze, K. S., Quesnel, B., Beyne-Rauzy, O., Cluzeau, T., Voso, M. T., Mazure, D., Vellenga, E., Greenberg, P. L., Hellstrom-Lindberg, E., Zeidan, A. M., Laadem, A., Benzohra, A., Zhang, J., Rampersad, A., Linde, P. G., Sherman, M. L., Komrokji, R. S. & List, A. F., 29-Nov-2018, In : Blood. 132, 5 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern

    Berger, G., Gerritsen, M., Yi, G., Koorenhof-Scheele, T. N., Kroeze, L. I., Stevens-Kroef, M., Yoshida, K., Shiraishi, Y., van den Berg, E., Schepers, H., Huls, G., Mulder, A. B., Ogawa, S., Martens, J. H. A., Jansen, J. H. & Vellenga, E., 2019, In : Blood. 3, 20, p. 3111-3122 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (381) »

ID: 1461464